{"transactions":[{"id":890714,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option","published_at":"2026-02-20T19:46:50.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":53300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant"}],"balance_after":53300,"derivative":{"exercise_price":28.06,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":53300},"source":{"system":"sec-edgar","filing":"0001933414-26-000037","document":"wk-form4_1771634807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341426000037/wk-form4_1771634807.xml","form_type":"4"}},{"id":890713,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2026-02-20T19:46:50.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":39900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting. The RSUs vest in annual installments over a period of four years, with 1/4th of the total shares underlying the RSU vesting on each one-year anniversary of the date of grant."}],"balance_after":48538,"source":{"system":"sec-edgar","filing":"0001933414-26-000037","document":"wk-form4_1771634807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341426000037/wk-form4_1771634807.xml","form_type":"4"}},{"id":940075,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2026-01-13T20:43:37.000Z","date":"2026-01-12","kind":"sale","planned":true,"acquired":false,"shares":10758,"price":32.1364,"value":345723.3912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $31.90 to $32.37. The Reporting Person undertakes to provide\nto the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nranges set forth in this footnote (2) to this Form 4."}],"balance_after":8638,"source":{"system":"sec-edgar","filing":"0001693134-26-000002","document":"wk-form4_1768355015.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000169313426000002/wk-form4_1768355015.xml","form_type":"4"}},{"id":1000272,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"exercise","planned":false,"acquired":false,"shares":6613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The stock option vests as to 25% of the total number of shares of common stock subject to the option on the first anniversary of the grant date, and as to 1/48th of  the total number of shares of common stock subject to the option on each monthly anniversary thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F15","text":"Since the date of the Reporting Person's last ownership report, 8,499 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse."}],"balance_after":4888,"derivative":{"exercise_price":15.44,"expiration_date":"2033-03-17","underlying":"Common Stock","underlying_shares":6613},"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000271,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"exercise","planned":false,"acquired":false,"shares":44079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The stock option vests as to 25% of the total number of shares of common stock subject to the option on the first anniversary of the grant date, and as to 1/48th of  the total number of shares of common stock subject to the option on each monthly anniversary thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F14","text":"Since the date of the Reporting Person's last ownership report, 64,329 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse."}],"balance_after":91592,"derivative":{"exercise_price":14.25,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":44079},"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000270,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"exercise","planned":false,"acquired":false,"shares":34414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The stock option vests as to 25% of the total number of shares of common stock subject to the option on the first anniversary of the grant date, and as to 1/48th of  the total number of shares of common stock subject to the option on each monthly anniversary thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F13","text":"Since the date of the Reporting Person's last ownership report, 42,442 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse."}],"balance_after":20662,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":34414},"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000269,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"exercise","planned":false,"acquired":false,"shares":20547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F11","text":"Since the date of the Reporting Person's last ownership report, 13,779 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse."}],"balance_after":135674,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":20547},"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000268,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":32718,"price":46.8848,"value":1533976.8864,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.4900 to $47.3600. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (9) to this Form 4."}],"balance_after":19396,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000267,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":38900,"price":45.9277,"value":1786587.53,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.4800 to $46.4725. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (8) to this Form 4."}],"balance_after":52114,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000266,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":8456,"price":45.1805,"value":382046.308,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.4700 to $45.4600. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7) to this Form 4."}],"balance_after":91014,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000265,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":4142,"price":43.5015,"value":180183.213,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.1700 to $44.0500. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4."}],"balance_after":99470,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000264,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":8485,"price":42.3404,"value":359258.294,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.1000 to $43.0400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4."}],"balance_after":103612,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000263,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":12952,"price":41.6522,"value":539479.2944,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.0550 to $42.0400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."}],"balance_after":112097,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000262,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":1561,"price":42.6794,"value":66622.5434,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.5100 to $42.9150. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":125049,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000261,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":11295,"price":41.8709,"value":472931.8155,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.4500 to $42.2800. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":126610,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000260,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":1015,"price":42,"value":42630.0,"ownership":{"direct":true},"balance_after":137905,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000259,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"exercise","planned":false,"acquired":true,"shares":6613,"price":15.44,"value":102104.72,"ownership":{"direct":true},"balance_after":138920,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000258,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"exercise","planned":false,"acquired":true,"shares":44079,"price":14.25,"value":628125.75,"ownership":{"direct":true},"balance_after":132307,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000257,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"exercise","planned":false,"acquired":true,"shares":34414,"price":16,"value":550624.0,"ownership":{"direct":true},"balance_after":88228,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1000256,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-11-13T19:01:37.000Z","date":"2025-11-11","kind":"exercise","planned":false,"acquired":true,"shares":20547,"price":10.2,"value":209579.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Since the date of the Reporting Person's last ownership report, 83,598 shares of common stock were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse."}],"balance_after":53814,"source":{"system":"sec-edgar","filing":"0001933414-25-000152","document":"wk-form4_1763078493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000152/wk-form4_1763078493.xml","form_type":"4"}},{"id":1018466,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-10-15T19:04:39.000Z","date":"2025-10-13","kind":"sale","planned":true,"acquired":false,"shares":3392,"price":42.2561,"value":143332.6912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.1600 to $42.3400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."}],"balance_after":116865,"source":{"system":"sec-edgar","filing":"0001933414-25-000130","document":"wk-form4_1760569476.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000130/wk-form4_1760569476.xml","form_type":"4"}},{"id":1018465,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-10-15T19:04:39.000Z","date":"2025-10-13","kind":"sale","planned":true,"acquired":false,"shares":7366,"price":41.9021,"value":308650.8686,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.1362 to $42.1300. The Reporting Person undertakes to provide\nto the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Since the date of the Reporting Person's last ownership report, 5,311 shares of common stock were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse."}],"balance_after":120257,"source":{"system":"sec-edgar","filing":"0001933414-25-000130","document":"wk-form4_1760569476.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000130/wk-form4_1760569476.xml","form_type":"4"}},{"id":1079109,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-07-30T20:12:01.000Z","date":"2025-07-30","kind":"sale","planned":false,"acquired":false,"shares":8425,"price":15.0983,"value":127203.1775,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.063 to $15.130. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."}],"balance_after":132934,"source":{"system":"sec-edgar","filing":"0001933414-25-000081","document":"wk-form4_1753920718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000081/wk-form4_1753920718.xml","form_type":"4"}},{"id":1079108,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-07-30T20:12:01.000Z","date":"2025-07-30","kind":"sale","planned":false,"acquired":false,"shares":51500,"price":14.7023,"value":757168.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.06 to $15.06. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":141359,"source":{"system":"sec-edgar","filing":"0001933414-25-000081","document":"wk-form4_1753920718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000081/wk-form4_1753920718.xml","form_type":"4"}},{"id":1079107,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-07-30T20:12:01.000Z","date":"2025-07-29","kind":"sale","planned":false,"acquired":false,"shares":807,"price":14.0048,"value":11301.8736,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.01. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":192859,"source":{"system":"sec-edgar","filing":"0001933414-25-000081","document":"wk-form4_1753920718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000081/wk-form4_1753920718.xml","form_type":"4"}},{"id":1079106,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-07-30T20:12:01.000Z","date":"2025-07-28","kind":"sale","planned":false,"acquired":false,"shares":12946,"price":14.0432,"value":181803.2672,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.20. The Reporting Person undertakes to provide\nto the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nranges set forth in this footnote (1) to this Form 4."}],"balance_after":193666,"source":{"system":"sec-edgar","filing":"0001933414-25-000081","document":"wk-form4_1753920718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000081/wk-form4_1753920718.xml","form_type":"4"}},{"id":1087365,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-07-15T17:01:27.000Z","date":"2025-07-11","kind":"sale","planned":true,"acquired":false,"shares":10758,"price":14.4501,"value":155454.1758,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.3012 to $14.6546. The Reporting Person undertakes to provide\nto the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This balance includes 2,030 shares purchased under the Mineralys Therapeutics, Inc. 2023 Employee Stock Purchase Plan that were not previously reported."}],"balance_after":206612,"source":{"system":"sec-edgar","filing":"0001933414-25-000077","document":"wk-form4_1752613283.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000077/wk-form4_1752613283.xml","form_type":"4"}},{"id":1171845,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-04-15T20:36:00.000Z","date":"2025-04-11","kind":"sale","planned":true,"acquired":false,"shares":10757,"price":12.0558,"value":129684.2406,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.78 to $12.35. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":215340,"source":{"system":"sec-edgar","filing":"0001933414-25-000046","document":"wk-form4_1744763754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000046/wk-form4_1744763754.xml","form_type":"4"}},{"id":1249629,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option","published_at":"2025-02-24T18:59:52.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month anniversary following the date of grant."}],"balance_after":170000,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001933414-25-000020","document":"wk-form4_1740441586.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000020/wk-form4_1740441586.xml","form_type":"4"}},{"id":1302623,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-01-15T21:46:09.000Z","date":"2025-01-13","kind":"sale","planned":true,"acquired":false,"shares":100,"price":9.63,"value":963.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023."}],"balance_after":226097,"source":{"system":"sec-edgar","filing":"0001933414-25-000005","document":"wk-form4_1736995563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000005/wk-form4_1736995563.xml","form_type":"4"}},{"id":1302622,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2025-01-15T21:46:09.000Z","date":"2025-01-13","kind":"sale","planned":true,"acquired":false,"shares":10657,"price":9.0927,"value":96900.9039,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $8.60 to $9.52. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":226197,"source":{"system":"sec-edgar","filing":"0001933414-25-000005","document":"wk-form4_1736995563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341425000005/wk-form4_1736995563.xml","form_type":"4"}},{"id":1386704,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2024-10-15T16:22:25.000Z","date":"2024-10-11","kind":"sale","planned":true,"acquired":false,"shares":10757,"price":13.5729,"value":146003.6853,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $13.24 to $13.76. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":236854,"source":{"system":"sec-edgar","filing":"0001933414-24-000047","document":"wk-form4_1729023737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341424000047/wk-form4_1729023737.xml","form_type":"4"}},{"id":1455348,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2024-07-12T16:37:59.000Z","date":"2024-07-11","kind":"sale","planned":true,"acquired":false,"shares":10757,"price":13.1444,"value":141394.3108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.93 to $13.43. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This balance includes 2,906 shares purchased under the Mineralys Therapeutics, Inc. 2023 Employee Stock Purchase Plan that were not previously reported."}],"balance_after":247611,"source":{"system":"sec-edgar","filing":"0001933414-24-000034","document":"wk-form4_1720816673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341424000034/wk-form4_1720816673.xml","form_type":"4"}},{"id":1480731,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Common Stock","published_at":"2024-06-13T17:33:32.000Z","date":"2024-06-11","kind":"sale","planned":true,"acquired":false,"shares":96815,"price":12.9393,"value":1252718.3295,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.79 to $13.29. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This balance includes 1,466 shares purchased under the Mineralys Therapeutics, Inc. 2023 Employee Stock Purchase Plan that were not previously reported."}],"balance_after":255462,"source":{"system":"sec-edgar","filing":"0001933414-24-000027","document":"wk-form4_1718314405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341424000027/wk-form4_1718314405.xml","form_type":"4"}},{"id":1640986,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option","published_at":"2024-02-15T16:26:23.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total number of shares of Common Stock subject to the option on the first anniversary of the grant date, and as to 1/48th of  the total number of shares of Common Stock subject to the option on each monthly anniversary thereafter."}],"balance_after":200000,"derivative":{"exercise_price":14.25,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001628280-24-005065","document":"wk-form4_1708032366.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000162828024005065/wk-form4_1708032366.xml","form_type":"4"}},{"id":1943105,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Secretary"}}],"security":"Stock Option","published_at":"2023-03-21T18:47:54.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total number of shares of Common Stock subject to the option on the first anniversary of the grant date, and as to 1/48th of  the total number of shares of Common Stock subject to the option on each monthly anniversary thereafter."}],"balance_after":20000,"derivative":{"exercise_price":15.44,"expiration_date":"2033-03-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001933414-23-000020","document":"wf-form4_167943885949772.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000193341423000020/wf-form4_167943885949772.xml","form_type":"4"}},{"id":2011016,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Chief Bus. Off. and Secy."}}],"security":"Common Stock","published_at":"2023-02-16T16:54:40.000Z","date":"2023-02-14","kind":"purchase","acquired":true,"shares":6250,"price":16,"value":100000.0,"ownership":{"direct":true},"balance_after":350811,"source":{"system":"sec-edgar","filing":"0001628280-23-003924","document":"wf-form4_167658446540333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000162828023003924/wf-form4_167658446540333.xml","form_type":"4"}},{"id":2020008,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO, Chief Bus. Off. and Secy."}}],"security":"Stock Option","published_at":"2023-02-13T21:01:27.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":97518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total number of shares of Common Stock subject to the option on the first anniversary of the grant date, and as to 1/48th of  the total number of shares of Common Stock subject to the option on each monthly anniversary thereafter."}],"balance_after":97518,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":97518},"source":{"system":"sec-edgar","filing":"0001628280-23-003424","document":"wf-form4_167634007134725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000162828023003424/wf-form4_167634007134725.xml","form_type":"4"}},{"id":3203597,"issuer":{"id":90076,"kind":"organization","name":"Fresh Tracks Therapeutics, Inc.","symbol":"FRTX"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-18T16:30:15.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":20000,"price":1.54,"value":30800.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":1.54,"exercise_date":"2021-03-16","expiration_date":"2030-03-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001214659-20-002727","document":"marketforms-48373.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/819050/000121465920002727/marketforms-48373.xml","form_type":"4"}},{"id":3668222,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-08T16:32:37.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\"). 6.25% of the shares will vest on May 7, 2019 and the remaining 93.75% of the shares will vest in equal monthly installments thereafter over 45 months, such that the stock option shall be fully vested on the four-year anniversary of the date of grant, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant."}],"balance_after":74000,"derivative":{"exercise_price":2.96,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0001209191-19-008536","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000120919119008536/doc4.xml","form_type":"4"}},{"id":4063030,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-02-13T17:02:18.000Z","date":"2018-02-13","kind":"purchase","acquired":true,"shares":9090,"price":5.5,"value":49995.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased through the Issuer's follow-on public offering."}],"balance_after":10540,"source":{"system":"sec-edgar","filing":"0001209191-18-009625","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000120919118009625/doc4.xml","form_type":"4"}},{"id":4079377,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-02T20:17:47.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\"). 6.25% of the shares will vest on April 30, 2018 and the remaining 93.75% of the shares will vest in equal monthly installments thereafter over 45 months, such that the stock option shall be fully vested on the four-year anniversary of the date of grant, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant."}],"balance_after":80000,"derivative":{"exercise_price":7.5,"expiration_date":"2028-01-30","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-18-007267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000120919118007267/doc4.xml","form_type":"4"}},{"id":4273587,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-06-23T19:07:55.000Z","date":"2017-06-22","kind":"purchase","acquired":true,"shares":200,"price":7.55,"value":1510.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.50 to $7.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001209191-17-041768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000120919117041768/doc4.xml","form_type":"4"}},{"id":4442787,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":65421,"kind":"person","name":"Levy Adam Scott","position":1,"cik":"0001693134","reported_name":"Levy Adam Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-16T20:25:10.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\"). The shares vest in 48 equal monthly installments beginning on February 16, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant."}],"balance_after":87500,"derivative":{"exercise_price":11.01,"expiration_date":"2027-02-15","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001209191-17-011779","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693134/000120919117011779/doc4.xml","form_type":"4"}}]}